ZNF90P1

Across TCGA pan-cancer cohorts, ZNF90P1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of ZNF90P1’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where ZNF90P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF90P1 is over-expressed in tumor, although a few such as KICH and KIRC show the opposite, repressed pattern.

CHOL, COAD, and KICH are the cancer types where ZNF90P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF90P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	All	All	+0.043	.034	4	view →
COAD	All	All	+0.030	.008	4	view →
KICH	Female	All	−0.046	<.001	3	view →
KIRC	Male	III,IV	−0.025	.002	2	view →
HNSC	All	All	+0.010	.036	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

ZNF90P1–CHOL

Open the CHOL breakdown →